TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Phase 2 Completed
23 enrolled 12 charts
TOGAR
Phase 2 Terminated
3 enrolled
Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer
Phase 2 Completed
78 enrolled 14 charts
PERIOP-PC
Phase NA Completed
379 enrolled 15 charts
Safety and Efficacy of Telatinib in Combination With Keytruda in Subjects With Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular Carcinoma
Phase 2 Completed
16 enrolled 13 charts
CAPOX, Bevacizumab and Trastuzumab for Patients With HER2-Positive Metastatic Esophagogastric Cancer
Phase 2 Completed
37 enrolled 11 charts
Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy
Phase NA Completed
52 enrolled 8 charts
Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer
Phase 2 Completed
74 enrolled 12 charts
Pembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by Surgery
Phase 1/2 Completed
31 enrolled 20 charts
PROCEED
Phase 2 Completed
35 enrolled 8 charts
Blood Tests for Gastritis and Gastric Neoplasms
Completed
1,490 enrolled 8 charts
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Phase 3 Completed
405 enrolled 11 charts
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Phase NA Completed
128 enrolled 24 charts
FDG-PET Directed Treatment in Improving Response in Patients With Locally Advanced Stomach or Gastroesophageal Junction Cancer
Phase 2 Terminated
5 enrolled 11 charts
Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma
Phase 2 Completed
35 enrolled 13 charts
HIPEC for Peritoneal Carcinomatosis
Phase 2 Completed
51 enrolled 12 charts
Checkpoint Inhibitor and Radiotherapy for Recurrent Gastric Cancer (CIRCUIT)
Phase 1/2 Completed
41 enrolled 8 charts
Advanced Gastrointestinal Endoscopic Imaging
Phase NA Terminated
3 enrolled 6 charts
Phase 2 Study of Telomelysin (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma
Phase 2 Completed
17 enrolled 13 charts
A Study Evaluating Safety and Efficacy of Niraparib in Patients With Previously Treated Metastatic Esophageal/Gastroesophageal Junction/Proximal Gastric Adenocarcinoma
Phase 2 Terminated
14 enrolled 11 charts
A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies
Phase 2 Completed
24 enrolled 10 charts
KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer
Phase 2 Completed
36 enrolled 11 charts
Cost-minimization Analysis of Gastric Cancer Treatments in Hong Kong
Completed
58 enrolled 8 charts
Perioperative Chemo and Pembrolizumab in Gastric Cancer
Phase 2 Completed
49 enrolled 10 charts
FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma
Phase 2 Completed
39 enrolled 17 charts
Epacadostat and Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Junction or Gastric Cancer
Phase 2 Completed
3 enrolled 12 charts
PIPAC-nabpac
Phase 1 Completed
20 enrolled 16 charts
Afatinib and Paclitaxel in Patients With Advanced HER2-Positive Trastuzumab-Refractory Advanced Esophagogastric Cancer
Phase 2 Completed
42 enrolled 9 charts
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies
Phase NA Completed
351 enrolled 15 charts
MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients)
Phase NA Completed
43 enrolled 10 charts
Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer
Phase 2 Completed
37 enrolled 8 charts
A Single-Arm Pilot Study of Adjuvant Pembrolizumab Plus Trastuzumab in HER2+ Esophagogastric Tumors With Persistent Circulating Tumor DNA Following Curative Resection
Phase 2 Terminated
1 enrolled 8 charts
Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer
Phase 2 Completed
88 enrolled 14 charts
PRO-YOU
Phase NA Completed
44 enrolled 28 charts
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer
Phase 2 Completed
20 enrolled 10 charts
CEPAFIRI
Phase 2 Completed
42 enrolled 8 charts
Compare the Oncological Benefit of Deep Neuromuscular Block in Gastric Cancer Obesity Patient
Phase 3 Completed
196 enrolled 11 charts
Effect of Multi-Media Tool on Enrollment in Oncology Clinical Trials
Completed
120 enrolled 12 charts
DOS
Phase 1 Completed
34 enrolled 13 charts
A Trial of ZD6474, Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiation Therapy Followed by Surgery
Phase 1 Completed
9 enrolled 10 charts
FOLFIRINOX
Phase 2 Completed
67 enrolled 14 charts
FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer
Phase 2 Completed
39 enrolled 11 charts
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
Phase 3 Completed
546 enrolled 11 charts
Cetuximab, Paclitaxel, Carboplatin & Radiation for Esoph, Gastroesoph & Gastric Cancer
Phase 2 Completed
60 enrolled 9 charts
Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ)
Phase 2 Completed
58 enrolled 7 charts
FOLFOX +/- Ziv-Aflibercept for Esophageal and Gastric Cancer
Phase 2 Completed
64 enrolled 11 charts
Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer
Phase 2 Terminated
7 enrolled 3 charts
Trial of Adjuvant Chemotherapy for Gastric Cancer
Phase 3 Completed
528 enrolled 8 charts
Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer
Phase 1 Completed
22 enrolled 6 charts
Capecitabine and Cisplatin (XP)+Sorafenib in Advanced Gastric Cancer (AGC): Sorafenib+XP
Phase 1/2 Completed
22 enrolled 11 charts